Watch GDRX. Know when insiders buy.
One email the day a filing lands. Free.
Work order
57
WATCH · insiders 25, shorts 88
Insiders, 90 days
−$9.7M
net selling · 0 buys, 14 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E 87.0DIV YIELD —FCF YIELD —REV TTM $785.2M −1.8%NET INCOME $16.2M −53.0%NET DEBT $198.9M52W 1.87 – 5.03NEXT EARNINGS Nov 3SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $200.4M | −1.3% | — | $23.6M | $8.5M | −33.5% | 0.02 | $80.8M | $362K | $80.5M | Aug 5 |
| Q1 2026 · Mar 31 | $194M | −4.4% | — | $14M | $1.2M | −89.4% | 0.00 | $11.8M | $1.1M | $10.7M | Aug 5 |
| Q4 2025 · Dec 31derived | $194.8M | −1.9% | — | $22.7M | $5.4M | −19.5% | 0.02 | $32.9M | $1.2M | $31.6M | Feb 26 |
| Q3 2025 · Sep 30 | $196M | +0.4% | — | $14.6M | $1.1M | −71.8% | 0.00 | $76M | $1.7M | $74.3M | Nov 4 |
| Q2 2025 · Jun 30 | $203.1M | +1.2% | — | $26.8M | $12.8M | +91.9% | 0.04 | $49.6M | $390K | $49.2M | Aug 5 |
| Q1 2025 · Mar 31 | $203M | +2.6% | — | $23.4M | $11.1M | — | 0.03 | $9.4M | $142K | $9.3M | Aug 5 |
| Q4 2024 · Dec 31derived | $198.6M | +1.0% | — | $18.2M | $6.7M | — | 0.02 | $44.7M | $162K | $44.6M | Feb 26 |
| Q3 2024 · Sep 30 | $195.3M | +8.5% | — | $20.4M | $4M | — | 0.01 | $86.9M | $403K | $86.5M | Nov 4 |
| Q2 2024 · Jun 30 | $200.6M | — | — | $19.9M | $6.7M | — | 0.02 | $9.7M | $268K | $9.4M | Nov 4 |
| Q1 2024 · Mar 31 | $197.9M | — | — | $7.4M | −$1M | — | 0.00 | $42.6M | $407K | $42.2M | Nov 4 |
| Q4 2023 · Dec 31derived | $196.6M | — | — | −$18.3M | −$25.9M | — | -0.06 | $15.9M | $409K | $15.5M | Feb 26 |
| Q3 2023 · Sep 30 | $180M | — | — | −$38.3M | −$38.5M | — | -0.09 | $60.3M | $194K | $60.1M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $796.9M | — | $87.5M | $30.4M | 3.8% | 0.09 | $167.9M | $3.5M | $164.4M | $216.4M | — |
| FY2024 · to Dec 31 | $792.3M | — | $65.8M | $16.4M | 2.1% | 0.04 | $183.9M | $1.2M | $182.7M | $158.8M | — |
| FY2023 · to Dec 31 | $750.3M | — | −$27M | −$8.9M | -1.2% | -0.02 | $138.3M | $1M | $137.2M | $104M | — |
| FY2022 · to Dec 31 | $766.6M | — | $1.7M | −$32.8M | -4.3% | -0.08 | $146.8M | $4M | $142.8M | $101.7M | — |
| FY2021 · to Dec 31 | $745.4M | — | $13.4M | −$25.3M | -3.4% | -0.06 | $178.8M | $4.6M | $174.2M | $0 | — |
| FY2020 · to Dec 31 | $550.7M | — | −$275.7M | −$293.6M | -53.3% | -1.07 | $131.3M | $20.6M | $110.8M | $0 | — |
Every number comes from GoodRx Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.